Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Issues Revised GMP Draft; Compliance Expected In Stages

This article was originally published in The Tan Sheet

Executive Summary

China's latest draft guideline on good manufacturing practices for drugs offers clarity on a few key points but still leaves huge gaps that need to be filled

You may also be interested in...



China's Aging Population Spurs OTC Sales, Looks For More Options

China's over-the-counter drug market grew more than 30 percent from 2007 to 2009 to more than RMB 90 billion ($13 billion), according to health care market intelligence provider IMS Health

China's Aging Population Spurs OTC Sales, Looks For More Options

China's over-the-counter drug market grew more than 30 percent from 2007 to 2009 to more than RMB 90 billion ($13 billion), according to health care market intelligence provider IMS Health

China's Aging Population Spurs OTC Sales, Looks For More Options

China's over-the-counter drug market grew more than 30 percent from 2007 to 2009 to more than RMB 90 billion ($13 billion), according to health care market intelligence provider IMS Health

Related Content

Topics

UsernamePublicRestriction

Register

LL1131867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel